BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30918289)

  • 1. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
    Solanki V; Tiwari M; Tiwari V
    Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
    Solanki V; Tiwari V
    Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtractive proteomic analysis of antigenic extracellular proteins and design a multi-epitope vaccine against Staphylococcus aureus.
    Solanki V; Tiwari M; Tiwari V
    Microbiol Immunol; 2021 Aug; 65(8):302-316. PubMed ID: 33368661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach.
    Gupta N; Kumar A
    Microb Pathog; 2020 Oct; 147():104398. PubMed ID: 32771659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics design of multivalent chimeric vaccine for modulation of the immune system in Pseudomonas aeruginosa infection.
    Aminnezhad S; Abdi-Ali A; Ghazanfari T; Bandehpour M; Zarrabi M
    Infect Genet Evol; 2020 Nov; 85():104462. PubMed ID: 32682863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a chimeric vaccine against multiple isolates of Mycobacteroides - An integrative approach.
    Satyam R; Bhardwaj T; Jha NK; Jha SK; Nand P
    Life Sci; 2020 Jun; 250():117541. PubMed ID: 32169520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quest for Novel Preventive and Therapeutic Options Against Multidrug-Resistant
    Irum S; Andleeb S; Ali A; Rashid MI; Majid M
    Int J Pept Res Ther; 2021; 27(4):2313-2331. PubMed ID: 34393689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse vaccinology approach to design a vaccine targeting membrane lipoproteins of
    Sharma S; Solanki V; Tiwari V
    J Biomol Struct Dyn; 2023 Feb; 41(3):954-969. PubMed ID: 34939517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; GarcĂ­a-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
    Fereshteh S; Haririzadeh Jouriani F; Noori Goodarzi N; Torkamaneh M; Khasheii B; Badmasti F
    PLoS One; 2023; 18(8):e0289609. PubMed ID: 37535697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
    Jalal K; Khan K; Uddin R
    Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach.
    Hasan M; Azim KF; Imran MAS; Chowdhury IM; Urme SRA; Parvez MSA; Uddin MB; Ahmed SSU
    PLoS One; 2020; 15(8):e0237181. PubMed ID: 32813697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study.
    Nosrati M; Hajizade A; Nazarian S; Amani J; Namvar Vansofla A; Tarverdizadeh Y
    Mol Immunol; 2019 Dec; 116():106-116. PubMed ID: 31634814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Immuno-Informatic Approach to Design a Multiepitope-Based Vaccine Against Emerging Multiple Drug Resistant
    Damas MSF; Mazur FG; Freire CCM; da Cunha AF; Pranchevicius MDS
    Front Immunol; 2022; 13():768569. PubMed ID: 35371033
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis.
    Priyadarshini V; Pradhan D; Munikumar M; Swargam S; Umamaheswari A; Rajasekhar D
    J Biomol Struct Dyn; 2014; 32(6):876-89. PubMed ID: 24404767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics design of a novel multi-epitope peptide vaccine to combat multi-drug resistant infections caused by Vibrio vulnificus.
    Abbas G; Zafar I; Ahmad S; Azam SS
    Eur J Pharm Sci; 2020 Jan; 142():105160. PubMed ID: 31751777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis core genome data mining for promising novel drug targets and chimeric vaccine candidates identification.
    Aslam M; Shehroz M; Ali F; Zia A; Pervaiz S; Shah M; Hussain Z; Nishan U; Zaman A; Afridi SG; Khan A
    Comput Biol Med; 2021 Sep; 136():104701. PubMed ID: 34364258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.